Zuventus
Healthcare, Wanbury, Macleods Pharma In Race For the Emerging Healthcare
Company at ILC 2013
India
Leadership Conclave brings tough competition as Indian Pharma Majors Wanbury,
Macleods, Bluecross,Wallace & Zuventus Healthcare eye to win the coveted
India’s Emerging Healthcare Company of the Year 2013 Title
Mumbai, Maharashtra,
India, Friday, 7th June 2013 : In the run up to the 4th Annual India
Leadership Conclave & Indian Affairs Business Leadership Awards 2013 (www.indialeadershipconclave.net/2013
) organized by Indian Affairs ( www.indianaffairs.tv
) in association with the Ministry of Corporate Affairs, Government of India
& several trade bodies, to be held in Mumbai at Hotel The Leela, Grand Ball
Room, on Friday,21st June 2013 in India, the prestigious nomination
for the prestigious “India’s Emerging
Healthcare Company of the Year 2013 Award title”has picked up the speed as
the Nation votes to select the Winner out od top five finalists screened. The
five pharma majors who are in the race are all Mumbai based companies such as Wanbury
Ltd,Macleods Pharmaceuticals Limited, Blue Cross Laboratories Ltd,Wallace
Pharmaceuticals Ltd,Zuventus Healthcare Ltd.
Given
to vote by the Juries to taste the mood of the nation since last 45 days, the
much awaited Leadership Conclave titled The
New India – Agenda For Change, Indian
masses have been voting to chose the Companies & Individuals who has
been remarkably successfully in the various categories such as telecommunication,IT,Education
&Training, Pharmaceutical, Healthcare, Food & Beverages, Automobile, Power
(Incl Renewable),Chemical & Fertilizer,FMCG & Consumer Appliances,
Hotel, Hospitality, Travel & Tourism, Financial Sector – Banking/Non
Banking finance companies/asset Management companies, BPOs (Business Process
Outsourcings) etc. “India’s Emerging Healthcare Company of the Year 2013 Award
Nomination is being widely discussed as Indian Healthcare Industry is in news
following two major developments first on the Novartis Patent Ruling &
Ranbaxy’s alleged violation of safety norms in medicines.
India
is now among the top five pharmaceutical emerging markets. The Indian pharma
industry has been growing at a compounded annual growth rate (CAGR) of more
than 15 per cent over the last five years and has significant growth
opportunities. The
domestic pharmaceutical market is expected to register a strong double-digit
growth of 13-14 per cent in 2013 on back of increasing sales of generic
medicines, continued growth in chronic therapies and a greater penetration in
rural markets.The cumulative drugs and pharmaceuticals sector has attracted
foreign direct investments (FDI) worth US$ 10,308.75 million during April 2000
to February 2013, according to the latest data published by Department of
Industrial Policy and Promotion (DIPP). Under these contexts, all five
pharmaceutical companies such as Wanbury Ltd,Macleods Pharmaceuticals Limited, Blue
Cross Laboratories Ltd,Wallace Pharmaceuticals Ltd,Zuventus Healthcare Ltd. Have
peformed well in the market & since the real winner is the one who beats
all odds & perform exceptional growth will be crowned the glory said, Award
Nomination Committee Chairman Satya Brahma.
Mumbai baseds Drug maker Wanbury,
has reported a standalone sales turnover of Rs 105.35 crore and a net loss of
Rs 8.20 crore for the quarter ended Dec '12. Other income for the quarter was
Rs 0.03 crore.For the quarter ended Dec 2011 the standalone sales turnover was
Rs 76.10 crore and net loss was Rs 13.41 crore.. Recently CCI is probing Macleods
pharma among five entities for 'engaging in anti-competition practices' in
granting stockist licence for medicines in Himachal Pradesh. Macleods has its presence in
over 30 countries with more than 300 registrations. The export range of
Macleods are manufactured in a unit that has QSM approval from WHO-Geneva, and
certifications from various International Regulatory Authorities like - USFDA,
MCC, UKMHRA, MOH Belarus, INVIMA Colombia, National Drugs Authority - Uganda,
Food and Drugs Board - Ghana, MCAZ Zimbabwe, Pharmacy and Poisons Board Kenya,
Pharmacy Board Tanzania etc. Owing to a high degree of technological
advancements, Macleods offers quality health care worldwide. It has strong
presence in essential therapies like TB, malaria & HIV. Wanbury Ltd is the
fastest growing pharma company with a Compounded Annual Growth Rate(CAGR) of
68% over the last 6 years.The company has strong presence in domestic
formulations,Active Pharmaceutical Ingredient(API) and Contract Research and
manufacturing Services(CRAMS).The company also has its presence in Europe in
formulations & the company has opened its office in Zurich,Switzerland for
its CRAMS business and incorporated Wanbury Global FZE in Middle East for
carrying out its trading activities in the year 2008. Indchemie
health specialities pvt. Ltd has been in the ethical pharma business for more
than two decades now, with leadership in few of the segments. It has a strong
back up of in-house manufacturing facility & has four pharmaceuticals
manufacturing units & the beta-lactam unit is having several commendable
approvals from african regulatory agencies like ethiopia, kenya and Malawi. Its
business focus is backed with the building up of captive manufacturing
operations and of complying with the regulatory standards of the advanced
markets.
Blue Cross Laboratories Ltd is a
leading Indian pharmaceutical company. This research based organization boasts
of more than two decades of sterling performance in the arena of healthcare
products. The company serves a global client base. The company operations run on
SAP. The Corporate office is connected with the production factories through RF
MPLS. The company has an annual sales turnover of around Rs.250 Crore. The
company employee base comprises over 1000 people. The
Wallace Group is a privately owned Pharmaceutical & Biotechnology Group
headquartered in Goa, India. Incorporated in the late 1960s as a joint venture
with Carter Wallace Inc. and Menezes family, the Wallace Group is primarily
engaged in the manufacture and marketing of formulation products in India as
well as abroad. The Group comprises Wallace Pharmaceuticals, Indipharma and
Goodwin Biotechnology Inc. The Wallace Group employs over 2300 personnel with
offices and facilities in several key locations in India and around the world.
The Wallace Group comprises of Wallace Pharmaceuticals , Wallace Laboratories,
Indi Pharma, GoodWinBio Tech & Trusts. Prakash Guha led Zuventus Healthcare
Limited is one of the fasdtest growing pharmaceutical company with an enviable
position in the Indian Healthcare Space with the turnover of more than 650
Crore. Zuventus Healthcare is a Joint Venture Company with Emcure, a leading
pharma giant & employs more than 2500 people & has a huge presence of
its products in pan India network.
The Grand Final of the Winner for the the Emerging Healthcare Company of
the year Award will be announced on Friday,21st June 2013 at the
Grand Ball Room of the Hotel Leela in Mumbai, India
No comments:
Post a Comment